Mettler-Toledo International Inc logo

Mettler-Toledo International Inc(MTD)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL RECENCY
2-STAR RATING
Consider higher Upturn Star rating
BUY for 41 days
PROFIT SINCE LAST BUY
+12.28% ▲
LAST CLOSE
$1705.66
11/19/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for MTD

11/19/2026: MTD (2-star) has a low Upturn Star Rating. Not recommended to BUY.

Mettler-Toledo International Inc is a prominent global supplier of precision instruments and services for laboratory, industrial, and food retailing applications. The company has a leading position in weighing and analytical measurement, supported by high operating margins and a robust direct service network. Its primary growth opportunity lies in secular life-science research trends, laboratory automation, and strict food safety regulations. However, investors must monitor risks related to macroeconomic cyclicality, industrial spending slowdowns, and a premium valuation multiple. The stock is best suited for growth-oriented investors looking for high-quality industrial franchise exposure while keeping an eye on capital expenditure cycles.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorStrong fit while signal remains positiveEnjoys steady secular drivers from life sciences research and automated laboratory infrastructure.
Momentum investorMixed fitPerformance depends on periodic industrial and tech capital expenditure cycles rather than explosive short-term momentum.
Value investorWeak fitTrades at a premium valuation multiple due to its consistent quality and high return on capital.
Dividend investorWeak fitThe company relies primarily on share repurchases rather than cash dividends to return capital.
Low-risk investorMediumOffers solid business stability and strong market positioning, though equity market volatility still applies.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityMediumStock price can experience fluctuations driven by broader market sentiment and quarterly industrial data.
Valuation riskMedium / highHigh price-to-earnings multiples leave less margin for error if earnings growth slows down.
Competition risk (analytical instruments and life science tools)MediumFaces continuous competition from well-capitalized life science instrumentation giants.
Business qualityStrongPossesses a high-quality franchise with strong margins and deeply embedded customer relationships.
Dividend incomeLow / noneInvestors looking for regular dividend income will not find meaningful payouts here.
Execution riskMediumMaintaining operational efficiency across global manufacturing and supply chains is critical for margin protection.

Key Highlights

Company Size Large-Cap Stock
Market Capitalization 33.94B USD
Price to earnings Ratio 37.04
1Y Target Price 1737.5
Price to earnings Ratio 37.04
1Y Target Price 1737.5
Volume (30-day avg) 188.5K shares
Beta 1.17
52 Weeks Range 1023.05 - 1806.58
Updated Date 11/19/2026
52 Weeks Range 1023.05 - 1806.58
Updated Date 11/19/2026
Dividends yield (FY) -
Basic EPS (TTM) 46.07

Sector & Industry Intelligence

Sector

Healthcare

Bullish
Sentiment
Strong Bullish
Momentum
Momentum Steady
BUY participation
61.0%
Active BUY / eligible
64 / 105
30-Day BUY Count Change
+16
Market state
Strong Bullish

The number of qualifying BUY stocks has remained relatively stable.

Industry

Diagnostics & Research

BUY participation
42.9%
Active BUY / eligible
6 / 14
30-Day BUY Count Change
-3

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Strong Uptrend
PRICE PATH

Strong Uptrend

The stock has maintained a strong upward price trend across the last three quarters.

Moderately Choppy
PRICE STABILITY

Moderately Choppy

The stock has experienced noticeable price swings while retaining some directional structure.

Analysis of Past Performance

Type Stock
Historic Profit 0.81%
Avg. Invested days 50
Today’s Advisory Consider higher Upturn Star rating
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 3.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/19/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
MTD receives a 4-star rating, supported by strong unit economics, solid company fundamentals, and solid quantitative characteristics. The rating is constrained by weak price momentum, and limited analyst upside.

Company Fundamentals

★★★★★
MTD has solid overall fundamentals (4 stars), with solid financial health, moderate growth momentum, and solid ownership. In FY2025 versus FY2024, moderate earnings growth (+0.7%) and strong cash generation (FCF margin 21.1%) are partially offset by moderate revenue growth (+4.0%), very low insider ownership of 0.45%.

Financial Health Rating

★★★★★
MTD's financial health is supported by solid cash strength, including free-cash-flow generation (21.1% of revenue). Liquidity is moderate (3 stars), which helps explain the 4-star overall score.

Growth Momentum Score

★★★★★
Revenue growth is MTD's strongest growth driver at +4.0% FY2025 versus FY2024 (moderate, 3 stars). By comparison, while free-cash-flow growth (-1.8%, slightly negative) holds the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 105.6% and approximately 99.4% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership is only 0.45%, which materially reduces the ownership score.

Top 5 Institutional Investors

BlackRock Inc 9.46%
Capital Research & Mgmt Co - Division 3 7.64%
Vanguard Capital Management, LLC 6.63%
Vanguard Portfolio Management, LLC 5.08%
State Street Corp 4.78%

Unit Economics (Per $1K Revenue)

★★★★★
MTD generates approximately $594 of gross profit, $278 of operating income, and $211 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Strong margins, cash conversion, and capital efficiency support the rating.

Economic Dimensions

★★★★★
Effective Tax Rate: 17.13%

Quantitative Style Profile

★★★★★
MTD has a high-quality, large-cap, liquid profile. Weak momentum is the primary drawback, while valuation that is moderately attractive rather than deeply discounted.

Style Classification

Quality Focused

Quality TiltLarge / Mega Cap StabilityHighly Liquid / Institution-Friendly

How Company Makes Money

Business areaWhat it includesRetail investor read
Laboratory InstrumentsSale of precision balances, pipettes, and analytical instruments to academic, pharma, and industrial labs.This is a stable, high-margin revenue driver tied to global scientific research budgets.
Industrial & Product InspectionHeavy-duty weighing scales, checkweighers, and metal detection systems for factories and food packaging.Provides cyclical exposure to manufacturing automation and stringent food safety compliance.
Geographic Exposure (Global)Revenues distributed across the Americas, Europe, and Asia/Rest of World.Diversified international footprint helps cushion regional economic downturns.

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date 2026-11-05
When After Market
Estimate 12.11
Actual 12.57

Profitability

Profit Margin 22.25%
Operating Margin (TTM) 27.82%

Management Effectiveness

Return on Assets (TTM) 20.23%
Return on Equity (TTM) 29.51%

Valuation

Trailing PE 37.04
Forward PE 33.22
Enterprise Value 36.53B
Price to Sales(TTM) 8.08
Enterprise Value 36.53B
Price to Sales(TTM) 8.08
Enterprise Value to Revenue 8.7
Enterprise Value to EBITDA 27.53
Shares Outstanding 19.89M
Shares Floating 19.78M
Shares Outstanding 19.89M
Shares Floating 19.78M
Percent Insiders 0.45
Percent Institutions 105.6

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.